Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Injection for Postoperative Pain in Gynecological Laparoscopic Surgeries
NCT07030647Completed
- Start
- Mar 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (3 arms). Primary endpoints: Postoperative Pain score assessed using the Visual Analog Scale at 24 hours and Time to First Analgesic Request at 24 hours. Started Mar 2024; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07030647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07030647.